Affiliation:
1. Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, India
2. Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona, United States
Abstract
:
Despite advances in treatment, individuals diagnosed with cancer are often at risk of suffering from metastasis, tumor recurrence, therapy resistance, and off-target toxicities from conventional chemo-, radio-, and endocrine- therapies. Drugs with potent anticancer and antimetastatic activity, but with milder side effects, can be combined with conventional therapies to increase efficacy, reduced therapy resistance, and decrease toxicity. Substantial data from epidemiological, cell culture, animal and clinical studies have established anticancer potential of nontoxic omega-3 fatty acids. This paper highlights the beneficial effects of omega-3 fatty acid treatment when used in combination with conventional therapies protect against metastasis, enhance therapeutic efficacy, and prevent the off-target toxicity caused by conventional therapies. These omega-3 fatty acids target therapy-induced central players NF-κB, and ROS to prevent drug-associated metastasis, therapy resistance, and off-target toxicities.
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献